The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AADI BIOSCIENCE INC | COM | 00032Q104 | 3,618,950 | 1,147,052 | SH | SOLE | 1,147,052 | 0 | 0 | |||
| ACRIVON THERAPEUTICS INC | COMMON STOCK | 004890109 | 2,439,527 | 405,237 | SH | SOLE | 405,237 | 0 | 0 | |||
| BICARA THERAPEUTICS | COM | 055477103 | 11,207,697 | 643,381 | SH | SOLE | 643,381 | 0 | 0 | |||
| BIOATLA INC | COM | 09077B104 | 2,383,746 | 4,032,046 | SH | SOLE | 4,032,046 | 0 | 0 | |||
| CANDEL THERAPEUTICS INC | COM | 137404109 | 16,836,110 | 1,939,644 | SH | SOLE | 1,939,644 | 0 | 0 | |||
| CARDIF ONCOLOGY INC | COM | 14147L108 | 6,259,617 | 1,442,308 | SH | SOLE | 1,442,308 | 0 | 0 | |||
| CG ONCOLOGY INC | COM | 156944100 | 32,451,449 | 1,131,501 | SH | SOLE | 1,131,501 | 0 | 0 | |||
| CYBIN INC | COM NEW | 23256X407 | 6,477,346 | 734,393 | SH | SOLE | 734,393 | 0 | 0 | |||
| MURAL ONCOLOGY PLC | COM | G63365103 | 4,141,174 | 1,286,079 | SH | SOLE | 1,286,079 | 0 | 0 | |||
| ONKURE THERAPEUTICS INC | CLASS A COM | 68277Q105 | 10,247,562 | 1,439,674 | SH | SOLE | 1,439,674 | 0 | 0 | |||
| OPTINOSE INC | COM NEW | 68404V209 | 2,824,391 | 422,813 | SH | SOLE | 422,813 | 0 | 0 | |||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 6,757,344 | 1,279,800 | SH | SOLE | 1,279,800 | 0 | 0 | |||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 12,017,159 | 2,450,711 | SH | SOLE | 2,450,711 | 0 | 0 | |||
| Q32 BIO INC. | COM | 746964105 | 2,763,782 | 803,425 | SH | SOLE | 803,425 | 0 | 0 | |||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | 10,920,802 | 1,971,264 | SH | SOLE | 1,971,264 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 8,244,318 | 2,001,048 | SH | SOLE | 2,001,048 | 0 | 0 | |||
| UROGEN PHARMA LTD | COM | M96088105 | 16,148,627 | 1,516,303 | SH | SOLE | 1,516,303 | 0 | 0 | |||
| X4 PHARMACEUTICALS INC | COM | 98420X103 | 5,363,093 | 7,310,650 | SH | SOLE | 7,310,650 | 0 | 0 | |||
| VYNE THERAPEUTICS INC | COM | 92941V308 | 1,530,850 | 456,970 | SH | SOLE | 456,970 | 0 | 0 | |||
| Y-MABS THERAPEUTICS INC | COM | 984241109 | 22,408,090 | 2,861,825 | SH | SOLE | 2,861,825 | 0 | 0 | |||